Market capitalization | $3.68b |
Enterprise Value | $4.75b |
P/E (TTM) P/E ratio | 18.19 |
EV/FCF (TTM) EV/FCF | 19.29 |
EV/Sales (TTM) EV/Sales | 4.27 |
P/S ratio (TTM) P/S ratio | 3.31 |
P/B ratio (TTM) P/B ratio | 2.19 |
Revenue growth (TTM) Revenue growth | -1.49% |
Revenue (TTM) Revenue | $1.11b |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
7 Analysts have issued a Prestige Brands Holdings, Inc. forecast:
7 Analysts have issued a Prestige Brands Holdings, Inc. forecast:
Jun '24 |
+/-
%
|
||
Revenue | 1,113 1,113 |
1%
1%
|
|
Gross Profit | 593 593 |
0%
0%
|
|
EBITDA | 362 362 |
6%
6%
|
EBIT (Operating Income) EBIT | 329 329 |
5%
5%
|
Net Profit | 205 205 |
343%
343%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Head office | United States |
CEO | Ronald Lombardi |
Employees | 570 |
Founded | 1996 |
Website | www.prestigebrands.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.